2(3H)-Dihydrofranolactone metabolites from Pleosporales sp. NUH322 as anti-amyotrophic lateral sclerosis drugs-Reference-Cited by-同舟云学术

2(3H)-Dihydrofranolactone metabolites from Pleosporales sp. NUH322 as anti-amyotrophic lateral sclerosis drugs

Published:2023-10-07 Issue:1 Volume:78 Page:146-159
ISSN:1340-3443
Container-title:Journal of Natural Medicines
language:en
Short-container-title:J Nat Med

Author:

Kusama-Eguchi Kuniko,Tokui Yuki,Minoura Ai,Yanai Yuta,Hirose Dai,Furukawa Megumi,Kosuge Yasuhiro,Miura Motofumi,Ohkoshi Emika,Makino Mitsuko,Minagawa Kimino,Matsuzaki Keiichi,Ogawa Yoshio,Watanabe Kazuko,Ohsaki Ayumi

Funder

A Grant from the Ministry of Education, Culture, Sports, Science, and Technology to promote 2001-multidisciplinary research projects

Grant-in-Aid for Scientific Research

Publisher

Springer Science and Business Media LLC

Subject

Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11418-023-01751-5.pdf

Reference52 articles.

1. Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA (2019) ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci 13:1310. https://doi.org/10.3389/fnins01310

2. Bensimon G, Lacomblez L, Meininger V, ALS/Riluzole Study Group (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585–591. https://doi.org/10.1056/NEJM199403033300901

3. Estevez AG, Stutzmann JM, Barbeito L (1995) Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol 280:47–53. https://doi.org/10.1016/0014-2999(95)00186-o

4. Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47(6 Suppl 4):S233–S241. https://doi.org/10.1212/wnl.47.6_suppl_4.233s

5. Akamatsu M, Yamashita T, Hirose N, Teramoto S, Kwak S (2016) The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice. Sci Rep 6:28649. https://doi.org/10.1038/srep28649